New!
Portfolio
Login
/
Sign Up
Search
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
close
close
Send us Feedback
GlaxoSmithKline (GSK)
SUMMARY
BULLS
BEARS
TOPICS
DATA CENTRAL
STOCK CHART
SEC FILINGS
BALANCE
INCOME
CASH FLOW
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
Cash Flow Statement (USD)
Annual
|
Quarterly
QUARTER ENDING
31-MAR
2012
30-JUN
2012
30-SEP
2012
31-DEC
2012
31-MAR
2013
Net Income
2.12B
1.97B
1.81B
1.37B
1.46B
Depreciation
-2.22B
380M
455M
534M
-904M
Amortization
0
0
0
0
0
Deferred Taxes
0
0
0
-2.70B
2.70B
Change In Working Capital
1.37B
157M
-2.97B
268M
2.96B
Other Non Cash Operating Items
-982M
129M
119M
3.64B
-3.83B
Cash From Operations
-8.10B
2.69B
-338M
3.10B
-5.18B
Capital Expenditures
1.66B
-556M
-647M
-846M
1.97B
Sale of Assets
115M
678M
215M
284M
-1.81B
Acquisitions
388M
-65.5M
-3.52B
-2.68M
3.61B
Investments
-83.2M
-16.7M
-70.9M
4.76M
115M
Other Investing Activities
-38.3M
-784M
-511M
-670M
1.88B
Cash from Investing
382M
-187M
-3.89B
-384M
3.80B
Dividends Paid
4.23B
-2.17B
-1.49B
-1.35B
5.12B
Sale / Purchase of Stock
-625M
-1.15B
-1.15B
-900M
3.47B
Net Borrowings
-27.2M
3.82B
918M
1.08B
-5.56B
Other Financing Cash Flows
4.14B
-296M
-282M
-473M
183M
Cash From Financing
7.72B
209M
-2.01B
-1.65B
3.20B
Foreign Exchange Effect
126M
-16.5M
-34.0M
-56.6M
343M
Net Change in Cash
129M
2.70B
-6.27B
1.01B
2.17B
Add Metric
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
Bet you've never seen portfolio analytics like these.
Introducing
SigFig
— from the creators of
Take Tour